Saponin-based adjuvant-induced dendritic cell cross-presentation is dependent on PERK activation

Lisa G. M. Huis in ’t Veld,Nataschja I. Ho,Melisssa Wassink,Martijn H. den Brok,Gosse J. Adema

DOI: https://doi.org/10.1007/s00018-022-04253-x

IF: 8

2022-04-09

Cellular and Molecular Life Sciences

Abstract:Abstract Saponin-based adjuvants (SBAs) are promising new adjuvants that stand out as they not only enforce CD4 + T cell-mediated immunity and antibody responses, but also induce an unprecedented level of antigen cross-presentation by dendritic cells (DC) and subsequent CD8 + T cell activation. We discovered that SBA’s ability to boost cross-presentation depends on the induction of lipid bodies (LBs). Moreover, the MHCII lo CD11b hi DC subset was identified to be most responsive to SBA-induced cross-presentation. The aim is to further unravel the mechanisms behind the induction of DC cross-presentation by SBAs. Here we show that SBAs specifically induce the PKR-like Endoplasmic Reticulum kinase (PERK) pathway and that SBA-induced DC cross-presentation is dependent on activation of the PERK pathway. PERK activation and LB formation are both crucial for SBA-induced cross-presentation and PERK inhibition has little or no effect on SBA-induced LB formation. SBA’s responsiveness, LB formation and PERK activation are specific for the MHCII lo CD11b hi DCs. These findings contribute to understanding the pathways involved in SBA-induced cross-presentation and immune activation which will ultimately lead to the development of vaccines with improved efficiency and safety.

cell biology,biochemistry & molecular biology